Why is Vijaya Diagnostic Centre Ltd falling/rising?

Recent Price Performance and Market Comparison

Vijaya Diagnostic Centre has outperformed its sector and benchmark indices in the short term. Over the past week, the stock surged by 5.79%, significantly ahead of the Sensex’s modest 0.64% gain. Similarly, in the last month, it recorded a 3.24% increase compared to the Sensex’s 0.83%. However, the year-to-date and one-year returns tell a more nuanced story, with the stock down 3.62% and 7.07% respectively, while the Sensex has risen 9.01% over the same one-year period. This divergence highlights the stock’s recent recovery after a period of underperformance relative to the broader market.

Technical Strength and Investor Activity

On 09 Feb, the stock’s delivery volume surged to 2.42 lakh shares, marking a 212.18% increase over the five-day average delivery volume. This heightened investor participation signals renewed confidence and buying interest. Additionally, Vijaya Diagnostic Centre is trading above all key moving averages—5-day, 20-day, 50-day, 100-day, and 200-day—indicating a strong technical momentum. The stock also touched an intraday high of ₹1,024.50, reinforcing the bullish sentiment among traders.

Fundamental Strengths Supporting the Rise

Vijaya Diagnostic Centre benefits from high management efficiency, reflected in a return on capital employed (ROCE) of 24.22%, which is a strong indicator of effective utilisation of capital. The company maintains a conservative capital structure with a low average debt-to-equity ratio of 0.06 times, reducing financial risk. Institutional investors hold a significant 43.69% stake, suggesting confidence from well-informed market participants who typically conduct thorough fundamental analysis before investing. These factors collectively underpin the stock’s recent gains and provide a foundation for sustained investor interest.

Challenges Tempering Long-Term Outlook

Despite the recent positive momentum, Vijaya Diagnostic Centre faces challenges that may restrain its long-term appreciation. The company’s net sales have grown at a modest annual rate of 13.10% over the past five years, while operating profit growth has been even slower at 7.27%. The half-yearly ROCE dipped to 16.57% in September 2025, indicating some softness in operational efficiency. Furthermore, the stock’s valuation appears stretched, with an enterprise value to capital employed ratio of 10.9, which is high relative to peers. The price-to-earnings-to-growth (PEG) ratio stands at 5.2, signalling that the stock is expensive compared to its earnings growth potential. This expensive valuation may explain why the stock has underperformed the broader BSE500 index, which returned 10.69% over the last year, while Vijaya Diagnostic Centre declined by 7.07% in the same period.

Conclusion: Why the Stock Is Rising Now

The recent rise in Vijaya Diagnostic Centre’s share price on 10-Feb is primarily driven by strong technical indicators and increased investor participation, supported by solid management efficiency and a healthy balance sheet. The stock’s outperformance relative to its sector and the broader market in the short term reflects renewed optimism among investors. However, the company’s expensive valuation and modest long-term growth prospects suggest caution for investors considering a longer holding period. While the stock has shown resilience and momentum recently, its premium pricing and historical underperformance relative to the market highlight the need for careful analysis before committing capital.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →